Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00937014 · ClinicalTrials.gov registry record · NA
Assessment of Growth of Infants Fed a New Formula
A NA study of Infant Nutrition, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 3
- Study locations
NCT00937014: Completed NA study of Infant Nutrition, sponsored by Société des Produits Nestlé (SPN).
NCT00937014 is a NA study of Infant Nutrition that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00937014, a NA study of Infant Nutrition, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this clinical trial is to assess growth (rate of weight gain in grams per day) of infants fed an infant formula with a whey isolate enriched with lactoferrin, during the first four months of life as compared to infants fed a standard infant formula.
Conditions Studied
Interventions
- OTHER standard infant formula
- OTHER Test formula
Study Locations (3)
Indiana
- Pedia Research, LLC - Newburgh
Kentucky
- Pedia Research, LLC - Owensboro
Maryland
- University of Maryland School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT00937014 record still lists
NCT00937014 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Infant Nutrition appearing as the primary indexed condition, and to 2 interventions - of which standard infant formula is the first listed.
NCT00937014 reports a single indexed study location in Indiana, Kentucky, Maryland.
Frequently Asked Questions
What is clinical trial NCT00937014 about?
NCT00937014 is a clinical study titled "Assessment of Growth of Infants Fed a New Formula". The purpose of this clinical trial is to assess growth (rate of weight gain in grams per day) of infants fed an infant formula with a whey isolate enriched with lactoferrin, during the first four months of life as compared to infants fed a standard infant formula.
What is the current status of trial NCT00937014?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2010-02. Estimated completion is 2013-06.
What conditions does trial NCT00937014 study?
This clinical trial studies the following conditions: Infant Nutrition.
What interventions are being tested in trial NCT00937014?
The interventions under investigation include: standard infant formula (OTHER), Test formula (OTHER).
Who is sponsoring clinical trial NCT00937014?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00937014 being conducted?
This trial has 3 study locations across Indiana, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00937014's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia